{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:59:50Z","timestamp":1788998390373,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum RWTH Aachen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Levonorgestrel-releasing intrauterine contraceptive devices (LNG-IUDs) are designed to exhibit only local hormonal effects. There is an ongoing debate on whether LNG-IUDs can have side effects similar to systemic hormonal medication. Benign background parenchymal enhancement (BPE) in dynamic contrast\u2013enhanced (DCE) MRI has been established as a sensitive marker of hormonal stimulation of the breast. We investigated the association between LNG-IUD use and BPE in breast MRI to further explore possible systemic effects of LNG-IUDs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Our hospital database was searched to identify premenopausal women without personal history of breast cancer, oophorectomy, and hormone replacement or antihormone therapy, who had undergone standardized DCE breast MRI at least twice, once with and without an LNG-IUD in place. To avoid confounding aging-related effects on BPE, half of included women had their first MRI without, the other half with, LNG-IUD in place. Degree of BPE was analyzed according to the ACR categories. Wilcoxon-matched-pairs signed-rank test was used to compare the distribution of ACR categories with vs. without LNG-IUD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Forty-eight women (mean age, 46 years) were included. In 24\/48 women (50% [95% CI: 35.9\u201364.1%]), ACR categories did not change with vs. without LNG-IUDs. In 23\/48 women (48% [33.9\u201362.1%]), the ACR category was higher with vs. without LNG-IUDs; in 1\/48 (2% [0\u20136%]), the ACR category was lower with vs. without LNG-IUDs. The change of ACR category depending on the presence or absence of an LNG-IUD proved highly significant (<jats:italic>p<\/jats:italic> &lt; 0.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The use of an LNG-IUD can be associated with increased BPE in breast MRI, providing further evidence that LNG-IUDs do have systemic effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key Points<\/jats:title>\n                <jats:p>\u2022 <jats:italic>The use of levonorgestrel-releasing intrauterine contraceptive devices is associated with increased background parenchymal enhancement in breast MRI.<\/jats:italic><\/jats:p>\n                <jats:p>\u2022 <jats:italic>This suggests that hormonal effects of these devices are not only confined to the uterine cavity, but may be systemic.<\/jats:italic><\/jats:p>\n                <jats:p>\u2022 <jats:italic>Potential systemic effects of levonorgestrel-releasing intrauterine contraceptive devices should therefore be considered.<\/jats:italic><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00330-022-08809-0","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T07:03:40Z","timestamp":1651907020000},"page":"7430-7438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Background parenchymal enhancement in contrast-enhanced MR imaging suggests systemic effects of intrauterine contraceptive devices"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4898-4294","authenticated-orcid":false,"given":"Luisa Charlotte","family":"Huck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Truhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Wilpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Zanderigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Raaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebba","family":"Dethlefsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane Katharina","family":"Kuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,7]]},"reference":[{"key":"8809_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/OAJC.S85755","volume":"7","author":"AL Nelson","year":"2016","unstructured":"Nelson AL, Massoudi N (2016) New developments in intrauterine device use: focus on the US. Open Access J Contracept 7:127","journal-title":"Open Access J Contracept"},{"key":"8809_CR2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1056\/NEJMsa1506575","volume":"374","author":"LB Finer","year":"2016","unstructured":"Finer LB, Zolna MR (2016) Declines in unintended pregnancy in the United States, 2008\u20132011. N Engl J Med 374:843\u2013852","journal-title":"N Engl J Med"},{"key":"8809_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.contraception.2014.03.013","volume":"89","author":"AA Danvers","year":"2014","unstructured":"Danvers AA, Stuart GS, Bryant AG (2014) Lawsuits against Mirena\u00ae: potential impact on public health. Contraception 89:489\u2013492","journal-title":"Contraception"},{"key":"8809_CR4","unstructured":"CDC, reproductive health, contraception, birth control methods. Available via https:\/\/www.cdc.gov\/reproductivehealth\/contraception\/index.htm On March 15, 2021"},{"key":"8809_CR5","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/aogs.13817","volume":"99","author":"L Conz","year":"2020","unstructured":"Conz L, Mota BS, Bahamondes L et al (2020) Levonorgestrel-releasing intrauterine system and breast cancer risk: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 99:970\u2013982. https:\/\/doi.org\/10.1111\/aogs.13817","journal-title":"Acta Obstet Gynecol Scand"},{"key":"8809_CR6","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jamapsychiatry.2016.2387","volume":"73","author":"CW Skovlund","year":"2016","unstructured":"Skovlund CW, M\u00f8rch LS, Kessing LV, Lidegaard \u00d8 (2016) Association of hormonal contraception with depression. JAMA Psychiatry 73:1154\u20131162","journal-title":"JAMA Psychiatry"},{"key":"8809_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.psyneuen.2017.02.025","volume":"80","author":"J Aleknaviciute","year":"2017","unstructured":"Aleknaviciute J, Tulen JHM, De Rijke YB et al (2017) The levonorgestrel-releasing intrauterine device potentiates stress reactivity. Psychoneuroendocrinology 80:39\u201345. https:\/\/doi.org\/10.1016\/j.psyneuen.2017.02.025","journal-title":"Psychoneuroendocrinology"},{"key":"8809_CR8","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s40264-018-0683-x","volume":"41","author":"J Slattery","year":"2018","unstructured":"Slattery J, Morales D, Pinheiro L, Kurz X (2018) Cohort study of psychiatric adverse events following exposure to levonorgestrel-containing intrauterine devices in UK general practice. Drug Safety 41:951\u2013958","journal-title":"Drug Safety"},{"key":"8809_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.contraception.2019.07.002","volume":"100","author":"HT Depypere","year":"2019","unstructured":"Depypere HT, Stanczyk FZ, Croubels S et al (2019) Breast levonorgestrel concentrations in women using a levonorgestrel-releasing intrauterine system. Contraception 100:299\u2013301. https:\/\/doi.org\/10.1016\/j.contraception.2019.07.002","journal-title":"Contraception"},{"key":"8809_CR10","doi-asserted-by":"publisher","unstructured":"Gossner J (2013) Marked increase of breast density due to a levonorgestrel-releasing intrauterine device. JBR-BTR 96:396. https:\/\/doi.org\/10.5334\/jbr-btr.529","DOI":"10.5334\/jbr-btr.529"},{"key":"8809_CR11","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1007\/s00330-012-2553-8","volume":"22","author":"V King","year":"2012","unstructured":"King V, Gu Y, Kaplan JB et al (2012) Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. Eur Radiol 22:2641\u20132647","journal-title":"Eur Radiol"},{"key":"8809_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/ijc.31370","volume":"143","author":"JD Brooks","year":"2018","unstructured":"Brooks JD, Sung JS, Pike MC et al (2018) MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women. Int J Cancer 143:823\u2013830","journal-title":"Int J Cancer"},{"key":"8809_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/jmri.24495","volume":"40","author":"NL Hansen","year":"2014","unstructured":"Hansen NL, Kuhl CK, Barabasch A, Strobel K, Schrading S (2014) Does MRI breast \u201cdensity\u201d (degree of background enhancement) correlate with mammographic breast density? J Magn Reson Imaging 40:483\u2013489","journal-title":"J Magn Reson Imaging"},{"key":"8809_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1148\/radiology.203.1.9122383","volume":"203","author":"M M\u00fcller-Schimpfle","year":"1997","unstructured":"M\u00fcller-Schimpfle M, Ohmenha\u00fcser K, Stoll P, Dietz K, Claussen CD (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 203:145\u2013149","journal-title":"Radiology"},{"key":"8809_CR15","doi-asserted-by":"crossref","unstructured":"Kajihara M, Goto M, Hirayama Y et al (2013) Effect of the menstrual cycle on background parenchymal enhancement in breast MR imaging. Magn Reson Med Sci:2012\u20130022","DOI":"10.2463\/mrms.2012-0022"},{"key":"8809_CR16","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1007\/s00330-015-4011-x","volume":"26","author":"H Preibsch","year":"2016","unstructured":"Preibsch H, Wanner L, Bahrs SD et al (2016) Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response. Eur Radiol 26:1590\u20131596. https:\/\/doi.org\/10.1007\/s00330-015-4011-x","journal-title":"Eur Radiol"},{"key":"8809_CR17","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.7314\/APJCP.2014.15.7.2939","volume":"15","author":"YJ Kim","year":"2014","unstructured":"Kim YJ, Kim SH, Choi BG et al (2014) Impact of radiotherapy on background parenchymal enhancement in breast magnetic resonance imaging. Asian Pac J Cancer Prev 15:2939\u20132943","journal-title":"Asian Pac J Cancer Prev"},{"key":"8809_CR18","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1148\/radiol.12112669","volume":"264","author":"V King","year":"2012","unstructured":"King V, Goldfarb SB, Brooks JD et al (2012) Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging. Radiology 264:670\u2013678","journal-title":"Radiology"},{"key":"8809_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/tbj.12002","volume":"18","author":"V King","year":"2012","unstructured":"King V, Kaplan J, Pike MC et al (2012) Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging. Breast J 18:527\u2013534","journal-title":"Breast J"},{"key":"8809_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1148\/radiol.13131198","volume":"271","author":"S Schrading","year":"2014","unstructured":"Schrading S, Schild H, K\u00fchr M, Kuhl C (2014) Effects of tamoxifen and aromatase inhibitors on breast tissue enhancement in dynamic contrast-enhanced breast MR imaging: a longitudinal intraindividual cohort study. Radiology 271:45\u201355. https:\/\/doi.org\/10.1148\/radiol.13131198","journal-title":"Radiology"},{"key":"8809_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1148\/radiol.11102156","volume":"260","author":"V King","year":"2011","unstructured":"King V, Brooks JD, Bernstein JL et al (2011) Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 260:50\u201360","journal-title":"Radiology"},{"key":"8809_CR22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1148\/radiol.2017170811","volume":"286","author":"KM Ray","year":"2018","unstructured":"Ray KM, Kerlikowske K, Lobach IV et al (2018) Effect of background parenchymal enhancement on breast MR imaging interpretive performance in community-based practices. Radiology 286:822\u2013829","journal-title":"Radiology"},{"key":"8809_CR23","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1200\/JCO.18.00378","volume":"37","author":"VA Arasu","year":"2019","unstructured":"Arasu VA, Miglioretti DL, Sprague BL et al (2019) Population-based assessment of the association between magnetic resonance imaging background parenchymal enhancement and future primary breast cancer risk. J Clin Oncol 37:954","journal-title":"J Clin Oncol"},{"key":"8809_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1148\/radiol.2015142304","volume":"276","author":"BN Dontchos","year":"2015","unstructured":"Dontchos BN, Rahbar H, Partridge SC et al (2015) Are qualitative assessments of background parenchymal enhancement, amount of fibroglandular tissue on MR images, and mammographic density associated with breast cancer risk? Radiology 276:371\u2013380","journal-title":"Radiology"},{"key":"8809_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1148\/radiol.2016161444","volume":"283","author":"CK Kuhl","year":"2017","unstructured":"Kuhl CK, Strobel K, Bieling H et al (2017) Supplemental breast MR imaging screening of women with average risk of breast cancer. Radiology 283:361\u2013370","journal-title":"Radiology"},{"key":"8809_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1148\/radiology.203.1.9122382","volume":"203","author":"CK Kuhl","year":"1997","unstructured":"Kuhl CK, Bieling HB, Gieseke J et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203:137\u2013144","journal-title":"Radiology"},{"key":"8809_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10549-018-4916-6","volume":"172","author":"JS Sung","year":"2018","unstructured":"Sung JS, Corben AD, Brooks JD et al (2018) Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI. Breast Cancer Res Treat 172:487\u2013496. https:\/\/doi.org\/10.1007\/s10549-018-4916-6","journal-title":"Breast Cancer Res Treat"},{"key":"8809_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/jmri.26762","volume":"51","author":"GJ Liao","year":"2020","unstructured":"Liao GJ, Henze Bancroft LC, Strigel RM et al (2020) Background parenchymal enhancement on breast MRI: a comprehensive review. J Magn Reson Imaging 51:43\u201361. https:\/\/doi.org\/10.1002\/jmri.26762","journal-title":"J Magn Reson Imaging"},{"key":"8809_CR29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1148\/121.3.545","volume":"121","author":"JN Wolfe","year":"1976","unstructured":"Wolfe JN (1976) Breast parenchymal patterns and their changes with age. Radiology 121:545\u2013552","journal-title":"Radiology"},{"key":"8809_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/bjc.1988.185","volume":"58","author":"CS Potten","year":"1988","unstructured":"Potten CS, Watson R, Williams G et al (1988) The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 58:163\u2013170","journal-title":"Br J Cancer"},{"key":"8809_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1148\/radiol.2351040012","volume":"235","author":"J-P Delille","year":"2005","unstructured":"Delille J-P, Slanetz PJ, Yeh ED et al (2005) Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging\u2014initial observations. Radiology 235:36\u201341","journal-title":"Radiology"},{"key":"8809_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1363\/46e0814","volume":"46","author":"C Dehlendorf","year":"2014","unstructured":"Dehlendorf C, Tharayil M, Anderson N et al (2014) Counseling about IUDs: a mixed-methods analysis. Perspect Sex Reprod Health 46:133\u2013140","journal-title":"Perspect Sex Reprod Health"},{"key":"8809_CR33","first-page":"561","volume":"5","author":"MN Beatty","year":"2009","unstructured":"Beatty MN, Blumenthal PD (2009) The levonorgestrel-releasing intrauterine system: safety, efficacy, and patient acceptability. Ther Clin Risk Manag 5:561","journal-title":"Ther Clin Risk Manag"},{"key":"8809_CR34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/jmri.24185","volume":"39","author":"SS Kang","year":"2014","unstructured":"Kang SS, Ko EY, Han BK et al (2014) Background parenchymal enhancement on breast MRI: influence of menstrual cycle and breast composition. J Magn Reson Imaging 39:526\u2013534. https:\/\/doi.org\/10.1002\/jmri.24185","journal-title":"J Magn Reson Imaging"},{"key":"8809_CR35","doi-asserted-by":"publisher","unstructured":"Sergison JE, Maldonado LY, Gao X, Hubacher D (2019) Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis. Am J Obstet Gynecol 220:440-448.e448. https:\/\/doi.org\/10.1016\/j.ajog.2018.12.008","DOI":"10.1016\/j.ajog.2018.12.008"},{"key":"8809_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jbi\/wbz022","volume":"1","author":"BN Dontchos","year":"2019","unstructured":"Dontchos BN, Rahbar H, Partridge SC, Lehman CD, DeMartini WB (2019) Influence of menstrual cycle timing on screening breast MRI background parenchymal enhancement and diagnostic performance in premenopausal women. J Breast Imaging 1:205\u2013211. https:\/\/doi.org\/10.1093\/jbi\/wbz022","journal-title":"J Breast Imaging"},{"key":"8809_CR37","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2214\/ajr.18.19960","volume":"214","author":"CH Lee","year":"2020","unstructured":"Lee CH, Bryce Y, Zheng J et al (2020) Outcome of screening MRI in premenopausal women as a function of the week of the menstrual cycle. AJR Am J Roentgenol 214:1175\u20131181. https:\/\/doi.org\/10.2214\/ajr.18.19960","journal-title":"AJR Am J Roentgenol"},{"key":"8809_CR38","doi-asserted-by":"publisher","first-page":"R232","DOI":"10.1186\/bcr779","volume":"6","author":"SO Pfleiderer","year":"2004","unstructured":"Pfleiderer SO, Sachse S, Sauner D et al (2004) Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res 6:R232\u2013R238. https:\/\/doi.org\/10.1186\/bcr779","journal-title":"Breast Cancer Res"},{"key":"8809_CR39","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1148\/rg.2018180035","volume":"38","author":"SL Heller","year":"2018","unstructured":"Heller SL, Young Lin LL, Melsaether AN, Moy L, Gao Y (2018) Hormonal effects on breast density, fibroglandular tissue, and background parenchymal enhancement. Radiographics 38:983\u2013996. https:\/\/doi.org\/10.1148\/rg.2018180035","journal-title":"Radiographics"},{"key":"8809_CR40","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1148\/rg.341135034","volume":"34","author":"CS Giess","year":"2014","unstructured":"Giess CS, Yeh ED, Raza S, Birdwell RL (2014) Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation. Radiographics 34:234\u2013247","journal-title":"Radiographics"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-08809-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-022-08809-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-08809-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T17:06:59Z","timestamp":1672938419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-022-08809-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["8809"],"URL":"https:\/\/doi.org\/10.1007\/s00330-022-08809-0","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,7]]},"assertion":[{"value":"1 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is the last author of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 observational\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}